Similar articles

• Auranofin.

  Davis P. Davis P. Clin Rheum Dis. 1984 Aug;10(2):369-83. Clin Rheum Dis. 1984. PMID: 6239742 Review.
• [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].

  Batlle Gualda E. Batlle Gualda E. Med Clin (Barc). 1985 May 25;84(20):834-9. Med Clin (Barc). 1985. PMID: 3928990 Review. Spanish. No abstract available.
• Review of auranofin, an oral chrysotherapeutic agent.

  Delafuente JC, Osborn TG. Delafuente JC, et al. Clin Pharm. 1984 Mar-Apr;3(2):121-7. Clin Pharm. 1984. PMID: 6426843 Review.
• [Experiences to date with oral gold therapy].

  Zeidler H. Zeidler H. Wien Klin Wochenschr Suppl. 1984;156:22-7. Wien Klin Wochenschr Suppl. 1984. PMID: 6442052 Review. German.
• A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.

  Barraclough D, Brook A, Brooks P, Boyden K, Thomas D, Tymms K. Barraclough D, et al. J Rheumatol Suppl. 1982 Jul-Aug;8:197-200. J Rheumatol Suppl. 1982. PMID: 6813485 Clinical Trial.